By performing whole-exome sequencing for 418 genes in carcinoids, LCNEC, and SCLC, the authors found MEN1 alterations almost exclusively in carcinoids, whereas TP53 and RB1 alterations were present in the high-grade carcinomas. The gene discussed is TP53; the disease is large cell neuroendocrine carcinoma.